Welcome to the Treace Medical Concepts. Third quarter, 2024 earnings conference call. (Operastor Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...
Revenue for the third quarter of 2024 was $45.1 million, representing an increase of 11% compared to $40.8 million in the third quarter of 2023. The increase was driven by product mix shift that ...
Andrew Kim, B.S. was honored with a “Best Paper” at the recent North American Spine Society (NASS) meeting in Chicago. His work (publication in progress), is titled, “Neurologic Adverse Events ...
The Nanoplasty™ MIS System is designed to deliver a reproducible 3D correction of the bunion deformity through a cosmetically appealing, hidden incision on the side of the foot and help patients get ...
The research topic will focus on: 1. Knee Preservation Techniques •Ligament repairs and reconstructions •Meniscus preservation, root tear repairs, and allograft transplantation •Cartilage regeneration ...
Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI) investors concerning the Company's possible violations ...
Supramalleolar Osteotomy Implants MarketThe global supramalleolar osteotomy implants market, valued at USD 1.4 billion in 2023, is projected to grow at a CAGR of 5.2%, surpassing USD 2.3 billion by ...